The results of the meta-analysis demonstrate a difference between those individuals treated with piracetam and those given placebo, both as significant odds ratio and as a favourable number needed to treat. While there may be problems in meta-analyses and the interpretation of the statistical results, the results of this analysis provide compelling evidence for the global efficacy of piracetam in a diverse group of older subjects with cognitive impairment.

Piracetam

Health conditions analyzed in this study

Mild Cognitive Impairment

1 supplement Moderately Positive Piracetam

Functions related to this study

Mental health

1 supplement Moderately Positive Piracetam

---

Body systems related to this study

Nervous System

1 supplement Piracetam